Research programme: vitamin D3 analogues - BioXell

Drug Profile

Research programme: vitamin D3 analogues - BioXell

Alternative Names: BXL-01-0120

Latest Information Update: 27 May 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioXell Inc
  • Class Hormonal steroids; Organic deuterium compounds; Secosteroids; Vitamin D analogues
  • Mechanism of Action Apoptosis stimulants; Calcitriol receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 16 Apr 2008 Early research in Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top